Inhibits Nrf2 signaling in human squamous carcinoma cells [77]Depletes intracellular GSH level and SOD2 in prostate cancer cells [97]Inhibits NFκB activation in human non-small lung cancer cells [176], pancreatic [177] and gastric cancer cells [178]. The gene discussed is NFE2L2; the disease is prostate cancer.